Table 1.
Study Participant Characteristics.
| Characteristics | CIS | MS | CIS/MS (combined) | Controls | Significance of difference CIS/MS compared to Controls (p) |
|---|---|---|---|---|---|
| n | 15 | 13 | 28 | 17 | |
| Females, n (%) | 9 (60%) |
11 (84.6%) |
20 (71.4%) |
9 (52.9%) |
0.21 (Pearson) |
| Age, median (95% CI) | 39.2 (23.4-54.3) |
33.7 (20.3-52.1) |
37.0 (20.3-54.3) |
34 (21-54) |
0.8 (Wilcoxon) |
| EBV status | |||||
| EBNA IgG Ab+, n (%) | 15 (100%) | 13 (100%) |
28 (100%) |
not available | not available |
| VCA IgM Ab+, n (%) | 3 (20%) |
4 (33.3%) |
7 (25.9%) |
not available | not available |